Effects of auricular acupressure on depression and anxiety in isolated COVID-19 patients: A single-blind randomized controlled trial

Effects of auricular acupressure on depression and anxiety in isolated COVID-19 patients

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2200006188

Enrollment

Unknown

Registered

2022-06-21

Start date

2022-06-09

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression and anxiety of isolated COVID-19 patients

Interventions

Sham group :Auricular acupressure on Knee, Wrist, Elbow, Shoulder

Auricular acupressure group :Auricular acupressure on Shenmen, Subcortex, Liver and Endocrine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) diagnosis of mild to moderate COVID-19 pneumonia based on clinical manifestations, abnormal findings in computed tomography scans and confirmation by real-time reverse transcriptase polymerase chain reaction assays from nasal and pharyngeal swab specimens; (2)aged 18-80 years old; (3) an index score of 50 or higher on the Zung Self-Rating Depression Scale (SDS); (4) an index score of 45 or higher on the Zung Self-Rating Anxiety Scale (SAS); (5) able to read and fill out the scales.

Exclusion criteria

Exclusion criteria: (1) history of severe mental illness; (2) not taking any antidepressants or anxiolytics within the one month before admission; (3) serious dysfunction of heart, lung, liver or kidney; (4) severe cognitive dysfunction; (5) dysphasia or aphasia.

Design outcomes

Primary

Measure	Time frame
Zung Self-Rating Depression Scale;Zung Self-Rating Anxiety Scale;	—

Countries

China

Contacts

Public ContactWei-dong Shen

shenweidong1018@163.com13391019193

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026